1. Home
  2. LEG vs GPCR Comparison

LEG vs GPCR Comparison

Compare LEG & GPCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Leggett & Platt Incorporated

LEG

Leggett & Platt Incorporated

HOLD

Current Price

$11.26

Market Cap

1.2B

ML Signal

HOLD

Logo Structure Therapeutics Inc.

GPCR

Structure Therapeutics Inc.

HOLD

Current Price

$34.90

Market Cap

1.2B

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
LEG
GPCR
Founded
1883
2016
Country
United States
United States
Employees
N/A
N/A
Industry
Home Furnishings
Sector
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.2B
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
LEG
GPCR
Price
$11.26
$34.90
Analyst Decision
Hold
Strong Buy
Analyst Count
4
8
Target Price
$10.00
$69.57
AVG Volume (30 Days)
2.2M
1.3M
Earning Date
10-27-2025
11-06-2025
Dividend Yield
1.79%
N/A
EPS Growth
N/A
N/A
EPS
1.61
N/A
Revenue
$4,172,899,999.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$6.93
N/A
Revenue Growth
N/A
N/A
52 Week Low
$6.48
$13.22
52 Week High
$12.30
$40.29

Technical Indicators

Market Signals
Indicator
LEG
GPCR
Relative Strength Index (RSI) 68.64 54.98
Support Level $11.26 $30.94
Resistance Level $12.03 $36.09
Average True Range (ATR) 0.38 2.50
MACD 0.23 -0.48
Stochastic Oscillator 77.00 41.07

Price Performance

Historical Comparison
LEG
GPCR

About LEG Leggett & Platt Incorporated

Leggett & Platt Inc designs and produces engineered components and products found in homes and automobiles. It operates its business through three segments namely Bedding Products, Specialized Products, and Furniture, Flooring, and Textile Products. It generates the majority of its revenue from Bedding Products. Serving a broad suite of customers around the world, Leggett & Platt's products include bedding components, automotive seat support, and lumbar systems, specialty bedding foam and private label finished mattresses, components for home furniture, and work furniture, flooring underlayment, adjustable beds, and various other products.

About GPCR Structure Therapeutics Inc.

Structure Therapeutics Inc is a clinical-stage biopharmaceutical company developing novel oral small-molecule therapeutics to treat a wide range of chronic diseases with unmet medical needs. Its differentiated technology platform leverages both structure-based drug discovery and expertise in computational chemistry to discover and develop small molecule therapeutics against G-protein coupled receptors (GPCRs). The group operates and manages its business as one reportable and operating segment, which is the business of research and development of medicines that target chronic diseases with unmet medical needs.

Share on Social Networks: